Skip to main content

What are you looking for?

Write the name, title or any keyword related to what you are looking for and select which content category it belongs to.

Activities

Jornada Nacional de Trasplantament Pediàtric

DIRECCIÓ I COORDINACIÓDra. Maria Mercadal Hally. Unitat d'Hepatologia i Trasplantament Hepàtic Pediàtric. Hospital Universitari Vall dHebron.Dra. Mercedes López González. Servei de Nefrologia Pediàtrica. Hospital Universitari Vall d’Hebron.DIRIGIT ATots els professionals que atene

Activities

Vall d'Hebron Talks by VHIR 'Targeting of monocytes and tumor-associated macrophages in cancer: lessons and perspectives'

Speaker: Dr. Julia Kzhyshkowska, Head of Dept. of Innate Immunity and Tolerance. Institute of Transfusion Medicine and Immunology, Medical Faculty Mannheim, Heidelberg University.ÀBSTRACTCancer is one of the leading causes of death, reduced quality of life and disability worldwide. can

Activities

The Lean Event 2025: Lean Day Global i Lean Day Sanitat

6 i 7 d'octubre de 2025ProgramaInscripcions

Activities

Conferència inaugural dels Màsters VHIR "The future is here to stay: gene, cell and gene-editing therapies in rare diseases" a càrrec de la Dra. Gemma Marfany

Ponent: Dra. Gemma Marfany, catedràtica de Genètica de la Universitat de Barcelona.És doctora en biologia i catedràtica de genètica de la Universitat de Barcelona. Delegada del Rector per a la divulgació científica i secretària de la Comissió de Bioètica de la Universita

Activities

Defensa de Tesi 'Asthma due to exposure to allergens and other environmental pollutants: inflammatory and immunologic response'

Doctorand: David Soler Segovia, grup de Recerca Pneumologia. Vall d'Hebron Institut de Recerca (VHIR) Directors: Dra. María Jesús Cruz Carmona i Dr. Xavier Muñoz Gall Tutora: Dra. María Jesús Cruz Carmona

Activities

Vall d'Hebron Talks by VHIR 'Actualització del Codi Sèpsia: on som i on anem'

Ponent: Dr. Marcio Borges Sa, Coordinador de la Unitat Multidisciplinària de Sèpsia de l'Hospital Son Llàtzer de Palma de Mallorca.A la sessió el Dr. Borges explicarà l'impacte d'implementació del codi sèpsia en diferents entorns, la necessitat d'individualització, referències del nou docu

Activities

1rst Mayo Clinic - Vall d'Hebron - NEPHROLOGY UPDATE

Oriol Bestard Matamoros Hospital Universitari Vall d´Hebron. Barcelona María José Soler Romeo Hospital Universitari Vall d´Hebron. Barcelona Sandra Herrmann, 1rst Mayo Clinic - Vall d´Hebron September 5-6, 2025 NEPHROLOGY UPDATE Directors: Mayo Clinic. Rochester, USA

News

The TRUSTroke project, coordinated by Vall d'Hebron, launches a clinical study to develop an AI-based solution for the follow-up of stroke patients

A retrospective study has been carried out with data from 11,000 patients to train artificial intelligence algorithms and adapt the Nora mobile application to different patient profiles.

News

Formation Bio Licenses First-in-Class Anti-CD226 Autoimmune Program from IMIDomics

Transaction expands Formation Bio's immunology pipeline with Phase 1 ready drug candidate.

News

Strong presence of VHIR at the European Alliance of Associations for Rheumatology Congress

15 researchers from the Rheumatology, Systemic Diseases and the Physiology and Pathophysiology of the Digestive Tract groups gave around 25 presentations.

News

Fundaluce supports research into a new therapeutic strategy for retinitis pigmentosa at Vall d’Hebron

Dr. Maria Llorián-Salvador, from the Diabetes and Metabolism Research Group at VHIR, is leading this project to identify new therapies for this inherited disease that causes progressive vision loss.

News

Vall d'Hebron shows the benefits on microbiota of a diet rich in vegetables, fruit, legumes and whole grains

The study, involving a thousand participants from different regions of Spain, shows that diet influences the diversity and composition of the microbiota and, therefore, health.

News

RBDCOV final event highlights legacy and lessons learned

The project, in which Vall d’Hebron participates, studied the Bimervax® vaccine in immunocompromised individuals and paediatric patients.

News

FDA grants orphan drug designation to a gene therapy for ALS developed in collaboration with VHIR

The treatment, licensed to Klotho Neurosciences, is based on a technology developed at the Universitat Autònoma de Barcelona (UAB) with the participation of VHIR.

Activities

Vall d'Hebron Talks by VHIR 'A multidimensional diagnostic approach for chronic obstructive pulmonary disease'

Speaker: Dr. Raúl San José Estépar, Co-Director, Applied Chest Imaging Laboratory-Lead Investigator, Brigham and Women’s Hospital-Associate Professor of Radiology, Harvard Medical SchoolIndividuals at risk for chronic obstructive pulmonary disease (COPD) but without spirometric airflo

News

Presentation of the VHIR Annual Report 2024

El informe incluye los datos y los resultados científicos e institucionales más destacados del centro durante el año.

News

The Spring 2025 edition of the Rising Innovators programme of VHIR has concluded

The aim of the initiative is to improve the management of innovation projects and their reach to patients and promote innovative and entrepreneurial culture.

News

First meeting of the regional expert group of ISMED-CLIM, a European project for the protection of vulnerable groups from the effects of climate change in the Mediterranean region

ISMED-CLIM is a European project coordinated by the University of Cyprus and has 27 partners from 11 countries, including the Parc Sanitari Pere Virgili and the Vall d'Hebron Research Institute, which lead the regional working group.

Activities

Graduació Curs Acadèmic 2024-2025- Màster en Investigació Biomèdica Traslacional - Màster en Gestió i Coordinació en assaigs clínics - Vall d'Hebron Institut de Recerca (VHIR)

17h Arribada, registre i fotografies17h30 Cerimònia de graduació- Benvinguda institucional- Discursos a càrrec de la Coordinació Acadèmica dels programes de màster- Discursos a càrrec dels estudiants- Lliurament de diplomes- Cloenda de l'acte19h Aperitiu